首页> 美国卫生研究院文献>other >Synthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5′-phosphate and Phosphonate Derivatives as P2 Receptor Antagonists
【2h】

Synthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5′-phosphate and Phosphonate Derivatives as P2 Receptor Antagonists

机译:Pyridoxal-6-芳基偶氮-5-磷酸盐和膦酸酯衍生物作为P2受体拮抗剂的合成及构效关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Novel analogs of the P2 receptor antagonist pyridoxal-5′-phosphate-6-phenylazo-2′,4′-disulfonate (PPADS) were synthesized. Modifications were made through functional group substitution on the sulfophenyl ring and at the phosphate moiety through the inclusion of phosphonates, demonstrating that a phosphate linkage is not required for P2 receptor antagonism. Substituted 6-phenylazo and 6-naphthylazo derivatives were also evaluated. Among the 6-phenylazo derivatives, 5′-methyl, ethyl, propyl, vinyl, and allyl phosphonates were included. The compounds were tested as antagonists at turkey erythrocyte and guinea-pig taenia coli P2Y1 receptors, in guinea-pig vas deferens and bladder P2X1 receptors, and in ion flux experiments by using recombinant rat P2X2 receptors expressed in Xenopus oocytes. Competitive binding assay at human P2X1 receptors in differentiated HL-60 cell membranes was carried out by using [35S]ATP-γ-S. A 2′-chloro-5′-sulfo analog of PPADS (C14H12O9N3ClPSNa), a vinyl phosphonate derivative (C15H12O11N3PS2Na3), and a naphthylazo derivative (C18H14O12N3PS2Na2), were particularly potent in binding to human P2X1 receptors. The potencies of phosphate derivatives at P2Y1 receptors were generally similar to PPADS itself, except for the p-carboxyphenylazo phosphate derivative C15H13O8N3PNa and its m-chloro analog C15H12O8N3ClPNa, which were selective for P2X vs. P2Y1 receptors. C15H12O8N3ClPNa was very potent at rat P2X2 receptors with an IC50 value of 0.82 μM. Among the phosphonate derivatives, [4-formyl-3-hydroxy-2-methyl-6-(2-chloro-5-sulfonylphenylazo)-pyrid-5-yl]methylphosphonic acid (C14H12-O8N3ClPSNa) showed high potency at P2Y1 receptors with an IC50 of 7.23 μM. The corresponding 2,5-disulfonylphenyl derivative was nearly inactive at turkey erythrocyte P2Y1 receptors, whereas at recombinant P2X2 receptors had an IC50 value of 1.1 μM. An ethyl phosphonate derivative (C15H15O11N3PS2Na3), whereas inactive at turkey erythrocyte P2Y1 receptors, was particularly potent at recombinant P2X2 receptors.
机译:合成了P2受体拮抗剂吡pyr醛-5'-磷酸盐-6-苯基偶氮-2',4'-二磺酸盐(PPADS)的新类似物。修饰是通过磺基苯环上的官能团取代和通过包含膦酸酯的磷酸基团取代而完成的,这表明P2受体拮抗作用不需要磷酸酯键。还评估了取代的6-苯基偶氮和6-萘基偶氮衍生物。在6-苯基偶氮衍生物中,包括5'-甲基,乙基,丙基,乙烯基和烯丙基膦酸酯。通过使用在非洲爪蟾卵母细胞中表达的重组大鼠P2X2受体,在火鸡红细胞和豚鼠taenia大肠杆菌P2Y1受体,豚鼠输精管和膀胱P2X1受体以及离子通量实验中,对这些化合物进行了测试。利用[ 35 S]ATP-γ-S对分化的HL-60细胞膜中的人P2X1受体进行竞争性结合测定。 PPADS(C14H12O9N3ClPSPSNa),乙烯基膦酸酯衍生物(C15H12O11N3PS2Na3)和萘偶氮衍生物(C18H14O 12 N 3 PS < sub> 2 Na 2 )在与人P2X 1 受体结合方面特别有效。除对羧基苯基偶氮磷酸酯衍生物C 15 H 13 O以外,P2Y 1 受体上磷酸酯衍生物的效力一般与PPADS相似。 8 N 3 PNa及其间氯类似物C 15 H 12 O 8 N 3 ClPNa,对P2X和P2Y 1 受体具有选择性。 C 15 H 12 O 8 N 3 ClPNa在大鼠P2X 2 受体,IC 50 值为0.82μM。在膦酸酯衍生物中,[4-甲酰基-3-羟基-2-甲基-6-(2-氯-5-磺酰基苯基偶氮)-吡啶-5-基]甲基膦酸(C 14 H < sub> 12 -O 8 N 3 ClPSNa)对P2Y 1 受体表现出高效能,IC 50 < / sub为7.23μM。相应的2,5-二磺酰基苯基衍生物在火鸡红细胞P2Y 1 受体上几乎没有活性,而在重组P2X 2 受体上具有IC 50 值为1.1μM。膦酸乙酯衍生物(C 15 H 15 O 11 N 3 PS 2 Na 3 )对火鸡红细胞P2Y 1 受体无活性,但对重组P2X 2 受体特别有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号